Researchers receive NIH grant to develop mRNA vaccines to de

A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.

Related Keywords

Roberts Langer , Vivek Mittal , Shaoyi Jiang , O Wayne Isom , Davidb Skinner , Nasser Altorki , Stevenm Lipkin , Emily Henderson , Geraldj Ford , Timothy Mcgraw , Weill Cornell Medicine Center , National Cancer Institute , Presbyterian Weill Cornell Medical Center , National Institutes Of Health , Interception Targeted Agent Discovery Program , Neuberger Berman Lung Cancer Laboratory , Cancer Biology Program At Weill Cornell Medicine , Epigenetics Program , Weill Cornell Medicine , National Institutes , Roland Harriman Professor , Joan Weill Department , Weill Cornell , Friends Professor , Meinig School , Biomedical Engineering , Cancer Genetics , Edward Meyer Cancer Center , Weill Cornell Medical , Genomics Industry Focus , Thoracic Surgery , Experimental Therapeutics Program , Meyer Cancer , Cancer Biology Program , Isom Professor , Cardiothoracic Surgery , Neuberger Berman Lung Cancer , Constitutional Mismatch Repair Deficiency , Cancer , Cancer Prevention , Research , Vaccine , Iochemistry , Enetic , Immune Response , Immune System , Laboratory , Lung Cancer , Alignant , Medicine , Proliferation , Na , Surgery , Yndrome , Humor ,